Despoina Manousaki

Research

Autoantibodies Consortium Diabetic Ketoacidosis Genetic Risk Score Metabolic Monitoring Population Screening Type 1 Diabetes

Latest funding

Canadian Population Screening for Risk of Type 1 Diabetes Research Consortium
CIHR · 2023 · Principal investigator
$5,999,552

All 1 grants and awards

Canadian Population Screening for Risk of Type 1 Diabetes Research Consortium

Principal investigatorCIHR2023Team Grant: CIHR-JDRF Type 1 Diabetes Screening Research Consortium

Principal investigators: Wherrett, Diane K; Delorme, Sasha; Chakraborty, Pranesh K; Hayeems, Robin Z; Kastner, Monika; L'Espérance, Audrey; Manousaki, Despoina; Marwaha, Ashish K; McGavock, Jonathan M; Pow, Conrad; Senior, Peter A; Tsui, Albert K; Verchere, Bruce C; Witteman, Holly M

Keywords: Autoantibodies; Consortium; Diabetic Ketoacidosis; Genetic Risk Score; Metabolic Monitoring; Population; Screening; Type 1 Diabetes

$5,999,552

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Mention their CIHR grant from 2023

Subject: Prospective PhD student: Autoantibodies Dear Professor Manousaki, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. Your research on autoantibodies connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Canadian Population Screening for Risk of Type 1 Diabetes Research Consortium" (2023), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]